v3.20.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 36,927,306 $ 12,108,582
Inventory 800,000 577,690
Vendor deposits 470,826 0
Prepaid expenses 453,822 141,221
Total current assets 38,651,954 12,827,493
Property and equipment, net 174,740 180,368
Right-to-use assets, net 513,464 714,342
Other assets:    
Patents, net 355,034 364,536
Trademarks 1,125 1,125
Prepaid expenses, long term 14,002 27,410
Deposits 101,839 101,839
Total assets 39,812,158 14,217,113
Current liabilities:    
Accounts payable and accrued expenses, including $97,645 and $39,674 to related parties as of June 30, 2020 and December 31, 2019, respectively 3,103,964 1,488,776
Dividends payable 67,453 128,478
Lease liability, short term 435,287 412,288
Total current liabilities 3,606,704 2,029,542
Lease liability, long term 88,574 311,131
Total debt 3,695,278 2,340,673
Commitments and contingencies (Note 11)
Preferred Stock 105,000 215,000
Equity:    
Preferred stock 0 0
Common stock, $0.001 par value, authorized 200,000,000 shares, 29,126,663 and 23,323,087 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 29,127 23,323
Additional paid in capital 168,499,417 115,910,058
Accumulated deficit (135,310,614) (104,786,769)
Total stockholders' equity attributable to BioSig Technologies, Inc. 33,217,930 11,146,612
Non-controlling interest 2,793,950 514,828
Total equity 36,011,880 11,661,440
Total liabilities and equity $ 39,812,158 $ 14,217,113

Source